Assignee
GENELABS TECH INC
US·71 granted patents·19 pending applications·1,976 citations·filing 1988–2009
Top patents by PatentIndex Score
90 records- 0195US6849713B2Compounds possessing antibacterial, antifungal or antitumor activityGENELABS TECH INC·Filed 2001·Granted Feb 1, 2005·92 cites·17 claims
- 0295US5538865AHepatitis C virus epitopesGENELABS TECH INC·Filed 1994·Granted Jul 23, 1996·141 cites·2 claims
- 0394US7432248B2Nucleoside derivatives for treating Hepatitis C virus infectionGENELABS TECH INC·Filed 2006·Granted Oct 7, 2008·52 cites·5 claims
- 0494US7064218B2Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activityGENELABS TECH INC·Filed 2002·Granted Jun 20, 2006·86 cites·36 claims
- 0594US6906103B2Compounds possessing antibacterial, antifungal or antitumor activityGENELABS TECH INC·Filed 2002·Granted Jun 14, 2005·87 cites·6 claims
- 0693US6107023ADNA amplification and subtraction techniquesGENELABS TECH INC·Filed 1988·Granted Aug 22, 2000·185 cites·14 claims
- 0792US7405204B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2006·Granted Jul 29, 2008·40 cites·48 claims
- 0892US7094768B2Nucleoside derivatives for treating hepatitis C virus infectionGENELABS TECH INC·Filed 2004·Granted Aug 22, 2006·47 cites·7 claims
- 0992US6114149AAmplification of mixed sequence nucleic acid fragmentsGENELABS TECH INC·Filed 1991·Granted Sep 5, 2000·192 cites·17 claims
- 1092US5578444ASequence-directed DNA-binding molecules compositions and methodsGENELABS TECH INC·Filed 1993·Granted Nov 26, 1996·82 cites·15 claims
- 1189US7151089B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Dec 19, 2006·37 cites·12 claims
- 1288US7157434B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Jan 2, 2007·35 cites·19 claims
- 1387US7511145B2Bicyclic heteroaryl derivativesGENELABS TECH INC·Filed 2004·Granted Mar 31, 2009·24 cites·11 claims
- 1487US5306619AScreening assay for the detection of DNA-binding moleculesGENELABS TECH INC·Filed 1993·Granted Apr 26, 1994·77 cites·17 claims
- 1586US6951880B2Aryl and heteroaryl compounds as antibacterial and antifungal agentsGENELABS TECH INC·Filed 2003·Granted Oct 4, 2005·28 cites·8 claims
- 1686US5744131ASequence-directed DNA-binding molecules compositions and methodsGENELABS TECH INC·Filed 1995·Granted Apr 28, 1998·53 cites·3 claims
- 1786US5716780AMethod of constructing sequence-specific DNA-binding moleculesGENELABS TECH INC·Filed 1995·Granted Feb 10, 1998·82 cites·9 claims
- 1884US7144868B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Dec 5, 2006·22 cites·21 claims
- 1984US7045513B1DHEA composition and methodGENELABS TECH INC·Filed 2000·Granted May 16, 2006·27 cites·14 claims
- 2083US5738990ASequence-directed DNA-binding molecules compositions and methodsGENELABS TECH INC·Filed 1995·Granted Apr 14, 1998·39 cites·5 claims
- 2183US5312837AMethod of treating viral infections with aryl macrocyclic compoundsGENELABS TECH INC·Filed 1991·Granted May 17, 1994·21 cites·8 claims
- 2282US6613517B2Nucleic acid binding assay and selection methodGENELABS TECH INC·Filed 2001·Granted Sep 2, 2003·20 cites·47 claims
- 2382US5766840AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Jun 16, 1998·31 cites·12 claims
- 2480US7189506B1DNA binding compound-mediated molecular switch systemGENELABS TECH INC·Filed 2000·Granted Mar 13, 2007·12 cites·6 claims
- 2580US5693463AMethod of ordering sequence binding preferences of a DNA-binding moleculeGENELABS TECH INC·Filed 1992·Granted Dec 2, 1997·56 cites·3 claims
- 2679US5869241AMethod of determining DNA sequence preference of a DNA-binding moleculeGENELABS TECH INC·Filed 1995·Granted Feb 9, 1999·47 cites·11 claims
- 2777US7425547B2Nucleoside derivatives for treating hepatitis C virus infectionGENELABS TECH INC·Filed 2003·Granted Sep 16, 2008·7 cites·15 claims
- 2875US6869765B2Sequence-directed DNA-binding molecules compositions and methodsGENELABS TECH INC·Filed 2001·Granted Mar 22, 2005·2 cites·1 claims
- 2975US6110662AHTLV-I/HTLV-II assay and methodGENELABS TECH INC·Filed 1994·Granted Aug 29, 2000·37 cites·15 claims
- 3075US6010849ASequence-directed DNA binding molecules compositions and methodsGENELABS TECH INC·Filed 1995·Granted Jan 4, 2000·35 cites·11 claims
- 3173US6552010B1Treatment of SLE with dehydroepiandrosteroneGENELABS TECH INC·Filed 2000·Granted Apr 22, 2003·9 cites·16 claims
- 3272US5726014AScreening assay for the detection of DNA-binding moleculesGENELABS TECH INC·Filed 1993·Granted Mar 10, 1998·39 cites·19 claims
- 3368US7244713B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Jul 17, 2007·3 cites·33 claims
- 3468US7202223B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Apr 10, 2007·3 cites·24 claims
- 3568US6605591B1Treatment of subnormal bone mineral densityGENELABS TECH INC·Filed 2000·Granted Aug 12, 2003·3 cites·20 claims
- 3666US7169918B2Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivativesGENELABS TECH INC·Filed 2004·Granted Jan 30, 2007·2 cites·51 claims
- 3766US6854468B2Treatment of subnormal bone mineral densityGENELABS TECH INC·Filed 2003·Granted Feb 15, 2005·2 cites·14 claims
- 3864US5874563AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Feb 23, 1999·15 cites·20 claims
- 3964US5436318AHepatitis C virus epitopesGENELABS TECH INC·Filed 1992·Granted Jul 25, 1995·15 cites·1 claims
- 4062US5849532AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Dec 15, 1998·9 cites·7 claims
- 4162US5824507AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Oct 20, 1998·12 cites·28 claims
- 4261US6838556B2Promoters for regulated gene expressionGENELABS TECH INC·Filed 2001·Granted Jan 4, 2005·1 cites·1 claims
- 4361US5338867APreparation of 4β- amino podophyllotoxin compoundsGENELABS TECH INC·Filed 1992·Granted Aug 16, 1994·9 cites·5 claims
- 4460US7141680B2Aromatic compounds possessing antifungal or antibacterial activityGENELABS TECH INC·Filed 2003·Granted Nov 28, 2006·3 cites·9 claims
- 4560US6355428B1Nucleic acid ligand interaction assaysGENELABS TECH INC·Filed 1999·Granted Mar 12, 2002·20 cites·38 claims
- 4660US5859230ANon-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereofGENELABS TECH INC·Filed 1996·Granted Jan 12, 1999·15 cites·1 claims
- 4760US5856134AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Jan 5, 1999·8 cites·6 claims
- 4860US2009081165A1Bicyclic heteroaryl derivativesGENELABS TECH INC·Filed 2008·Application pending·0 cites
- 4959US7612034B2Treatment of subnormal bone mineral densityGENELABS TECH INC·Filed 2004·Granted Nov 3, 2009·0 cites·25 claims
- 5056US2003170714A1Transcripts encoding immunomodulatory polypeptidesGENELABS TECH INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GENELABS TECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →